New HLA-A, -B, and -C locus-specific primers for PCR amplification from cDNA: application in clinical immunology

被引:10
作者
Bettinotti, MP [1 ]
Hadzikadic, L [1 ]
Ruppe, E [1 ]
Dhillon, G [1 ]
Stroncek, DS [1 ]
Marincola, FM [1 ]
机构
[1] NIH, Ctr Clin, Dept Transfus Med, Bethesda, MD 20892 USA
关键词
human leukocyte antigen; complementary deoxyribonucleic acid; polymerase chain reaction;
D O I
10.1016/S0022-1759(03)00233-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The individual cellular immune response to intracellular antigens is modeled by the highly polymorphic major histocompatibility complex (HLA) class I molecules. The epitopes presented and the T cell repertoire that recognizes them depend on the HLA constitution of the individual. Therefore, to monitor and to modify an individual's HLA class I-driven cellular immune response, it is necessary to know the HLA class I alleles of the person and the possible epitopes of the target antigen presented by those alleles. In particular, this is necessary in order to design peptide-based vaccines and immune therapies for the treatment of diseases caused by viruses, intracellular parasites or cancer, and to monitor the immune response during those treatments. We describe a new set of HLA-A, -B, and -C locus-specific primers for the polymerase chain reaction (PCR) amplification of the whole coding sequence of these genes from complementary DNA (cDNA). We describe their use for typing and for the production of a library of recombinant HLA class I genes. We discuss two downstream applications of this gene collection: production of soluble HLA molecules and discovery of new epitopes. Crown Copyright (C) 2003 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 12 条
[1]  
Bettinotti MP, 1998, J IMMUNOL, V161, P877
[2]   Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178 [J].
Bettinotti, MP ;
Panelli, MC ;
Ruppe, E ;
Mocellin, S ;
Phan, GQ ;
White, DE ;
Marincola, FM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (02) :210-216
[3]  
Cohen RS, 1999, HARVARD LIBR BULL, V10, P6
[4]  
DOMENA JD, 1993, TISSUE ANTIGENS, V42, P509
[5]   HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors [J].
Migueles, SA ;
Sabbaghian, MS ;
Shupert, WL ;
Bettinotti, MP ;
Marincola, FM ;
Martino, L ;
Hallahan, CW ;
Selig, SM ;
Schwartz, D ;
Sullivan, J ;
Connors, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2709-2714
[6]   A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12 [J].
Panelli, MC ;
Bettinotti, MP ;
Lally, K ;
Ohnmacht, GA ;
Li, Y ;
Robbins, P ;
Riker, A ;
Rosenberg, SA ;
Marincola, FM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4382-4392
[7]   Allele assignment for HLA-A, -B, and -C genes to the Tenth International Histocompatibility Workshop cell lines [J].
Prasad, VK ;
Yang, SY .
TISSUE ANTIGENS, 1996, 47 (06) :538-546
[8]   MHC MOLECULES AS PEPTIDE RECEPTORS [J].
RAMMENSEE, HG ;
FALK, K ;
ROTZSCHKE, O .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (01) :35-44
[9]   HLA CLASS-I SEQUENCE-BASED TYPING [J].
SANTAMARIA, P ;
LINDSTROM, AL ;
BOYCEJACINO, MT ;
MYSTER, SH ;
BARBOSA, JJ ;
FARAS, AJ ;
RICH, SS .
HUMAN IMMUNOLOGY, 1993, 37 (01) :39-50
[10]   Selection of the T cell repertoire [J].
Sebzda, E ;
Mariathasan, S ;
Ohteki, T ;
Jones, R ;
Bachmann, MF ;
Ohashi, PS .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :829-874